Image-guided therapy developer IMRIS has closed on its private placement of 10.6 million units worth an estimated total of $3 million.
The company offered each unit for 28.4 cents. Each unit consists of one common share and 1.25 common share of purchase warrants. The warrants can be converted to one common share four months from the date of issue and ending 5.5 years from the date of issue at a price of 36.9 cents per common share.
